CN112566630A - 类姜黄色素组合物的用途 - Google Patents

类姜黄色素组合物的用途 Download PDF

Info

Publication number
CN112566630A
CN112566630A CN201980052384.2A CN201980052384A CN112566630A CN 112566630 A CN112566630 A CN 112566630A CN 201980052384 A CN201980052384 A CN 201980052384A CN 112566630 A CN112566630 A CN 112566630A
Authority
CN
China
Prior art keywords
curcuminoids
curcumin
composition
food
curcuminoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980052384.2A
Other languages
English (en)
Chinese (zh)
Inventor
P·E·R·凡卡-伯顿
L·D·凡尔考
M·特农
M·韦纳尔
S·比尔迪克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan France Naturals SAS
Original Assignee
Naturex SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812776.1A external-priority patent/GB201812776D0/en
Priority claimed from GBGB1902266.4A external-priority patent/GB201902266D0/en
Application filed by Naturex SA filed Critical Naturex SA
Publication of CN112566630A publication Critical patent/CN112566630A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201980052384.2A 2018-08-06 2019-08-05 类姜黄色素组合物的用途 Pending CN112566630A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1812776.1 2018-08-06
GBGB1812776.1A GB201812776D0 (en) 2018-08-06 2018-08-06 New methods and uses
GBGB1902266.4A GB201902266D0 (en) 2019-02-19 2019-02-19 New methods and uses
GB1902266.4 2019-02-19
PCT/EP2019/071055 WO2020030612A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Publications (1)

Publication Number Publication Date
CN112566630A true CN112566630A (zh) 2021-03-26

Family

ID=67770463

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980052384.2A Pending CN112566630A (zh) 2018-08-06 2019-08-05 类姜黄色素组合物的用途

Country Status (9)

Country Link
US (3) US12059394B2 (https=)
EP (1) EP3833337A1 (https=)
JP (2) JP2021534105A (https=)
CN (1) CN112566630A (https=)
AU (1) AU2019320488B2 (https=)
BR (1) BR112021001403A2 (https=)
CA (2) CA3292034A1 (https=)
MX (1) MX2021000776A (https=)
WO (1) WO2020030612A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115028886A (zh) * 2022-06-21 2022-09-09 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208109B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种高生物利用度水溶姜黄素及其制备方法以及应用
CN113383881B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种液体水溶姜黄素及其制备方法以及应用
JP2025528917A (ja) * 2022-08-22 2025-09-02 ジボダン エス エー クルクミノイド、改変デンプンおよび／またはアカシアガム並びにサポニンを含む医薬用組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120322750A1 (en) * 2010-01-22 2012-12-20 Symrise Ag Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
CN103476432A (zh) * 2011-01-31 2013-12-25 瓦克化学股份公司 含有脂溶性物质的水溶液的制备方法
EP2721933A1 (de) * 2012-10-16 2014-04-23 Döhler GmbH Emulsion
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786775B1 (fr) * 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
JP5448511B2 (ja) * 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2011130696A (ja) * 2009-12-24 2011-07-07 Nihon Cornstarch Corp マルトデキストリンの製造方法
DE102011056111B4 (de) * 2011-12-06 2013-08-14 Sensient Colors Europe Gmbh Emulsion
WO2014202364A1 (en) * 2013-06-21 2014-12-24 Firmenich Sa Preparation of dried particles comprising menthol
US20160151440A1 (en) * 2013-08-19 2016-06-02 Aurea Biolabs Private Limited A Novel Composition of Curcumin with Enhanced Bioavailability
US10016363B2 (en) * 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
KR20180124133A (ko) * 2016-04-01 2018-11-20 산에이겐 에후.에후. 아이. 가부시키가이샤 고체 색소의 안정화 방법
JP6794190B2 (ja) * 2016-09-01 2020-12-02 株式会社ファンケル キマーゼ阻害用組成物
WO2018056444A1 (ja) * 2016-09-26 2018-03-29 三栄源エフ・エフ・アイ株式会社 クルクミン組成物
JP6986345B2 (ja) * 2016-11-18 2021-12-22 ロート製薬株式会社 経口組成物及びその製造方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120322750A1 (en) * 2010-01-22 2012-12-20 Symrise Ag Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
CN103476432A (zh) * 2011-01-31 2013-12-25 瓦克化学股份公司 含有脂溶性物质的水溶液的制备方法
EP2721933A1 (de) * 2012-10-16 2014-04-23 Döhler GmbH Emulsion
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115028886A (zh) * 2022-06-21 2022-09-09 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法
CN115028886B (zh) * 2022-06-21 2023-11-21 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法

Also Published As

Publication number Publication date
US20250144048A1 (en) 2025-05-08
CA3108123A1 (en) 2020-02-13
JP2025003947A (ja) 2025-01-14
MX2021000776A (es) 2021-06-15
JP2021534105A (ja) 2021-12-09
BR112021001403A2 (pt) 2021-04-27
KR20210041037A (ko) 2021-04-14
AU2019320488A1 (en) 2021-02-18
WO2020030612A1 (en) 2020-02-13
AU2019320488B2 (en) 2025-01-23
EP3833337A1 (en) 2021-06-16
US12059394B2 (en) 2024-08-13
US20220280448A1 (en) 2022-09-08
CA3292034A1 (en) 2026-03-02
US20240115519A1 (en) 2024-04-11
US12220388B2 (en) 2025-02-11

Similar Documents

Publication Publication Date Title
JP7525473B2 (ja) クルクミノイド組成物
US12220388B2 (en) Uses of curcuminoid compositions
Purpura et al. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects
EP2709607B1 (en) A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
Lang et al. Effects of α-casein on the absorption of blueberry anthocyanins and metabolites in rat plasma based on pharmacokinetic analysis
CN104427981A (zh) 包含莱菔硫烷或莱菔硫烷前体和蕈类提取物或粉末的组合物
CN101357883B (zh) 治疗自体免疫疾病的牛樟芝环己烯酮化合物及医药组成物
KR102957602B1 (ko) 커큐미노이드 조성물의 용도
CN113384541B (zh) 一种用于防治早期神经退行性疾病的鼻腔纳米自噬诱导剂及其制备方法
US11541093B2 (en) Pharmacological use of Cimicifuga extract
BR112021001405B1 (pt) Composição de curcuminoide, seu uso, processo para sua preparação, e produtos compreendendo tal composição
WO2023047401A1 (en) Targeted encapsulation strategies for treatment modalities
CN104379001B (zh) 获自酿造过程产生的生物质的脂肪粘结剂
JP6147593B2 (ja) コレステロール吸収抑制剤
Ka et al. Investigation Into the Antidiabetic Effects of a Developed Polyherbal Nanosuspension and Its Assessment.
Manikpuri et al. Development of Chitosan Microsphere-Based Herbal Formulations for Targeted Therapy in Obesity Management
FARER CoQ10sr Patented Delivery System Doubles CoQ10 Blood Levels

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination